Mefruside
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number |
7195-27-9 |
| ATC code | C03BA05 (WHO) |
| PubChem | CID 4047 |
| ChemSpider |
3907 |
| UNII |
X1NS9SNS92 |
| KEGG |
D01877 |
| Chemical data | |
| Formula | C13H19ClN2O5S2 |
| Molar mass | 382.88 g/mol |
| |
| |
| | |
Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]
It was developed by Bayer A.G. and is sold under the tradename Baycaron.
References
- ↑ Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.
| ||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
